Show
Sort by
-
- Journal Article
- A2
- open access
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
-
- Journal Article
- A1
- open access
AROMA : real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Association between outdoor air pollution and chronic rhinosinusitis patient reported outcomes
-
- Miscellaneous
- open access
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis
-
- Journal Article
- A1
- open access
Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds
-
Health-related quality of life impairment among patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 trial
(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(2). p.AB133-AB133 -
Rapid and sustained effects of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps : analysis of the SINUS-24 and SINUS-52 phase 3 trails
(2021) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. In American Journal of Respiratory and Critical Care Medicine 203(9, supplement S). p.A1345-A1345 -
International consensus statement on allergy and rhinology : rhinosinusitis 2021
-
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
-
- Journal Article
- A1
- open access
Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP
-
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial
-
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management
-
Surgery in nasal polyp patients : outcome after a minimum observation of 10 years
-
Role of biologics in chronic rhinosinusitis with nasal polyposis : state of the art review
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis : an EAACI position paper (vol 10, 1, 2020)
-
The role of mobile health technologies in allergy care : an EAACI position paper
-
- Journal Article
- A1
- open access
COVID-19 and olfactory dysfunction : an ENT perspective to the current COVID-19 pandemic
-
Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis
-
- Journal Article
- A1
- open access
Treatment of allergic rhinitis during and outside the pollen season using mobile technology : a MASK study
-
- Journal Article
- A1
- open access
Real-life assessment of chronic rhinosinusitis patients using mobile technology : the mySinusitisCoach project by EUFOREA
-
- Journal Article
- A1
- open access
Allergic respiratory disease care in the COVID-19 era : a EUFOREA statement
-
European position paper on rhinosinusitis and nasal polyps 2020
-
- Journal Article
- A1
- open access
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis : an EAACI position paper
-
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP
-
Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
-
Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis
-
- Journal Article
- A2
- open access
Three-dimensional morphing and Its added value in the rhinoplasty consult
-
Efficacy and safety of the 300 IR sublingual tablet for the treatment of house dust mite-associated allergic rhinitis : a multicentre, international, dbpc, randomized phase III clinical trial
-
Severe asthma : entering an era of new concepts and emerging therapies : highlights of the 4th International Severe Asthma Forum, Madrid, 2018
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research : the European Strategic Forum on Allergic Diseases
-
Rhinology future trends : 2017 EUFOREA debate on allergic rhinitis
-
Patient advisory board for chronic rhinosinusitis : a EUFOREA initiative
-
- Conference Paper
- C3
- open access
A randomized phase 3 study, SINUS-52, evaluating the efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps
-
Mobile technology offers novel insights into the control and treatment of allergic rhinitis : the MASK study
-
ARIApharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'
-
Dupilumab reduces need for systemic corticosteroid use, sinonasal surgery in patients with severe chronic rhinosinusitis with nasal polyps : pooled results from the SINUS- 24, SINUS- 52 phase 3 studies
-
Real-life assessment of chronic rhinosinusitis patients using mobile technology
-
2019 ARIA Care pathways for allergen immunotherapy
-
Mobile technology in allergic rhinitis : evolution in management or revolution in health and care?
-
- Journal Article
- A1
- open access
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma
-
From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity
-
The GALEN rhinosinusitis cohort : chronic rhinosinusitis with nasal polyps affects health-related quality of life
-
- Journal Article
- A1
- open access
The Global Allergy and Asthma European Network (GALEN) rhinosinusitis cohort : a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps
-
Dupilumab improves ACQ-5 items in CRSwNP patients with comorbid asthma
-
Dupilumab improves mental health measures in patients with chronic rhinosinusitis and nasal polyposis (CRSwNP)
-
ARIA 2016 executive summary : integrated care pathways for predictive, preventive and personalized medicine across the life cycle
-
Impact of chronic rhinosinusitis with nasal polyposis on quality of life by sino-nasal surgery history
-
Dupilumab improves all ACQ-5 individual items in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma : results from a phase 2a trial
-
- Conference Paper
- C3
- open access
Extent of sinus involvement in patients with bilateral nasal polyposis (NP) : baseline sinus ct scan results from a phase 2a study
-
The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps
-
Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma : results from a phase 2a trial
-
Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis : a randomized clinical trial
-
- Journal Article
- A1
- open access
Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers